Sign in
4/A

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-16-019189

Options or other derivatives

  • Chief Technical Officer acquired 137,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Watler Peter K. · Chief Technical Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2015-04-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +100,000 100,000 D
2015-04-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +37,500 37,500 I
Loading xslF345X03/doc4a.xml…